The FDA Said No — Now We Need Your Voice
Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed…
President's Letter
07/25/2025
The FDA Said No — Now We Need Your Voice
Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed…
|
|
06/06/2025
May in Review: A Marathon Month of Melanoma Awareness, Education, and Community
By Sam Guild, President, AIM at Melanoma Foundation Wow! May truly felt like running a marathon—and crossing the finish line…
|
05/01/2025
Hope, Purpose, and Progress: Melanoma Awareness Month with AIM
Dear Friend, May is Melanoma Awareness Month, a time to honor the progress made in the fight against this deadly…
|
12/12/2024
Navigating Melanoma Together: 2024 Podcast Wrap-Up
This special publication looks back over the 2024 Beyond the Clinic: Living Well with Melanoma podcast series, offering a comprehensive…
|
|
10/10/2024
Fall 2024 Newsletter
As we transition into fall, I wanted to take a moment to share some highlights from this busy spring and…
|
04/11/2024
President’s Letter | April 2024
From the Desk of Samantha Guild Happy Spring! Spring is a season of things new and renewed, and this newsletter…
|
05/01/2023
May is National Melanoma and Skin Cancer Awareness Month
Dear Friends, As most everyone in the melanoma community knows, May is National Melanoma and Skin Cancer Awareness Month. What…
|
11/16/2022
President’s Letter | November 2022
From the Desk of Samantha Guild November is the month to prioritize our gratitude, and I never tire of this…
|
09/27/2022
President’s Letter | September 2022
From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…
|
01/27/2022
President’s Letter | January 2022
From the Desk of Samantha Guild Happy 2022! I hope this year is joyful and healthy for you and…
|
Recent Posts
Sep. 09, 2025
Caring Through Loss: A Conversation on Bereavement
Sep. 05, 2025
Advocating for Patients: Letter to the FDA on RP1 Treatment Access
Sep. 04, 2025
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
Aug. 26, 2025
Back to AIM: Advocacy, Walks, and Fall Initiatives in Melanoma
Aug. 26, 2025